To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 2000 participants.
Also called NCT07098195
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 2,000 participants
- Sponsor
- Poly Medicure Limited
- Registry
-
NCT07098195
-
- Planned start
- (anticipated)
- Primary completion
- (anticipated)
- Completion
- (anticipated)
- Countries
- Not reported
- Registry status
- Not yet recruiting
Technical summary
Registry record NCT07098195. Allocation not applicable; no masking; primary purpose treatment. Start 2025-08-18 (anticipated); primary completion 2027-08-17 (anticipated). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- To Evaluate the Performance and Safety of RisoR Crest Everolimus Eluting Coronary Stent System
- Acronym
- PACIFIER
- Condition
- Coronary Artery Disease
- Condition
- Coronary Artery Stenosis
- Condition
- Percutaneous Coronary Intervention
- Condition
- de Novo Lesions in Native Coronary Arteries
- Intervention (Device)
- Coronary Stent
- Lead sponsor
- Poly Medicure Limited
Record details
- Record id
cardio:ct-nct07098195- Content hash
48641a86563a5032ec6dadcbe6ad4d2252e7a7c8032e59fcaf40ef8cf4898631